Illness	Number of cases
Hyperplasia of prostate (N40)	206
Malignant neoplasm of bladder - Malignant neoplasm of bladder unspecified (C67.9)	113
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21)	87
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by renal calculi (N13.20)	63
Malignant neoplasm of prostate (C61)	57
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8)	48
Obstructive and reflux uropathy (N13.3)	44
Unspecified renal colic (N23)	41
Malignant neoplasm of kidney except renal pelvis (C64)	31
Other disorders of urinary system - Urinary tract infection site not specified (N39.0)	29

Top 10 treatments

Treatment	Number
Injection or administration of medicines into the urinary bladder (8-132.3)	475
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0)	222
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40)	202
Insertion, exchange or removal of a ureteral stent (8-137.00)	162
(9-984.7)	131
(9-984.8)	118
Injection or administration of medicines into the urinary bladder (8-132.2)	92
Examination of the urethra and the urinary bladder by endoscopy (1-661)	82
Transfusion of blood, red blood cells or platelets from a donor to a recipient (8-800.c0)	63
Other procedure on the kidney, ureter, bladder or urethra (8-139.00)	60

Further information about the department

Out-patient accident insurance doctor approval

In-patient Employers’ Liability Insurance Association approval

Department key

Department key: 2200

Type of specialist department

Main Department

Hospital information and services for all specialist departments

Services

Quality

External comparative quality assurance

Further information

External quality assurance according to state law
No participation

External quality assurance according to the DMP

Diabetes mellitus Typ 1

Im Rahmen der Ermächtigung der Klinik für Kinder- und Jugendmedizin.

Teilnahme an sonstigen Verfahren der externen vergleichenden Qualitätssicherung

Implementation of resolutions of the Federal Joint Committee on quality assurance (G-BA)

No.	Explanation
CQ01	in Zusammenarbeit mit der Chirurgischen Klinik/Gefäßzentrum
CQ07	in vollem Umfang erfüllt; Weiterführende standortbezogene Informationen unter: www.perinatalzentren.org

Further training
pursuant to Article 136b, para. 1, sentence 1, no. 1 of the SGB

Number	Group
100	Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
83	Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
82	Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations

* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”

Accessibility

Accessibility information

General information

Research & teaching

Job	Explanation
Student training (clinical traineeship / internship year)
Project-related cooperation with colleges and universities	Teilnahme am SOS NET

Training

No.	Training in other healing professions	Comment
HB19	Nursing professionals
HB01	Nurse and health care worker (m/f)
HB02	Health and paediatric nurse (m/f)
HB10	Midwife (m/f)
HB05	Medical technical radiology assistant (MTRA) (m/f)
HB12	Medical technical laboratory assistant (MTLA) (m/f)